Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
GlaxoSmithKline PLC ADR
GSKCurrent price
1 651.5 GBX
+16.56 GBX (+1.01%)
Last closed
43.13 USD
Company
www.gsk.com
ISIN
US37733W2044
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
London Exchange
Capitalization
89 553 125 376 USD
Yield for 12 month
+19.48 %
1Y
3Y
5Y
10Y
15Y
GSK
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development, as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. Address: 980 Great West Road, Brentford, United Kingdom, TW8 9GS
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
46.07 USDP/E ratio
14.7349Dividend Yield
3.49 %Current Year
+39 843 191 659 USD
Last Year
+38 524 193 887 USD
Current Quarter
+10 357 548 241 USD
Last Quarter
+10 357 548 241 USD
Current Year
+27 919 662 000 USD
Last Year
+25 972 695 170 USD
Current Quarter
+7 623 649 472 USD
Last Quarter
+7 623 649 472 USD
Key Figures GSK
1 year
3 years
5 years
10 years
EBITDA
10 983 000 064 USD
Operating Margin TTM
PE Ratio
14.7349
Return On Assets TTM
9.56 %
PEG Ratio
1.5267
Return On Equity TTM
33.3 %
Wall Street Target Price
46.07 USD
Revenue TTM
31 445 999 616 USD
Book Value
3.52 USD
Revenue Per Share TTM
Dividend Share
0.6 USD
Quarterly Revenue Growth YOY
9.8 %
Dividend Yield
3.49 %
Gross Profit TTM
19 917 000 000 USD
Earnings per share
2.98 USD
Diluted Eps TTM
2.98 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
-28.2 %
Profit Margin
12.83 %
Dividend Analytics GSK
Dividend growth over 5 years
-16 %Continuous growth
–Payout Ratio 5 years average
68 %Dividend History GSK
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
1.53
Ex Dividend Date
16.08.2024
Forward Annual Dividend Yield
3.49 %
Last Split Factor
1226:1000
Payout Ratio
36.15 %
Last Split Date
22.07.2022
Dividend Date
10.10.2024
Stock Valuation GSK
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
14.7349
Forward PE
10.3842
Enterprise Value Revenue
2.5933
Price Sales TTM
2.8478
Enterprise Value EBITDA
10.0839
Price Book MRQ
4.7232
Financials GSK
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators GSK
For 52 weeks
32.44 USD
45.37 USD
50 Day MA
40.15 USD
Shares Short Prior Month
13 836 098
200 Day MA
40.45 USD
Short Ratio
4.43
Shares Short
9 646 992
Short Percent
0.72 %
BeatStart